Pharmacie, Hôpital universitaire Necker - Enfants Malades - APHP, Paris, France.
Pharmacie, Hôpital universitaire Necker - Enfants Malades - APHP, Paris, France; University of Paris-Sud, Department of Pharmacy, Laboratory "Matériaux et Santé" EA 401, 92296 Châtenay-Malabry, France.
Eur J Pharm Biopharm. 2020 Dec;157:175-182. doi: 10.1016/j.ejpb.2020.10.013. Epub 2020 Oct 24.
The aim of this study was to assess the impact of suspended drug by tablet crushing in our pediatric hospital in term of targeted dose and to identify parameters involved in the potential variability. Four usually crushed pediatric drug substances were selected: amiodarone, warfarin, hydrocortisone and captopril. Each tablet was crushed in a bag using a crusher device. Once crushed, a pre-determined volume of water was added using oral syringes before taking the necessary volume to obtain the targeted drug amount. For each drug, operators among pharmacy technicians and nurses investigated 2 targeted doses (high and low). Each suspension was assayed 3 times using the corresponding validated HPLC procedure. Statistical analysis was performed (GraphPad Prism®) to evaluate the impact of operators, the level of suction in bag, and actual drug doses. To investigate the impact of formulation change on syringe drug content, five generic drugs of amiodarone were selected. Syringes contents were compared using one-way ANOVA. Drug loss in syringe ranged from 8.1% to 54.1%. The drug loss represented 18.9% to 30.5% for amiodarone, 0.1% to 5.5% for captopril, 5.6% to 19.7% for warfarin and 5.0% to 30.7% for hydrocortisone. The comparison of level sampling of suspensions presented significant differences for amiodarone, hydrocortisone, and warfarin. Comparison of operators demonstrated significant difference between pharmacy technician and nurse (p = 0.0251). Finally, comparison of 5 generic drugs for amiodarone showed some statistical difference between the syringes content obtained when using the original medicine as compared to the generics. The physicochemical properties of each drug substance and the formulation of the drug product may both factor that should be considered. As a result, crushing tablets in water for oral administration needs a case by case assessment. Although appropriate pediatric formulations are lacking, suspend the crushed material in a given volume of water should be discouraged and not recommended because far from good practice.
本研究旨在评估我院儿科在经片剂粉碎后给药的靶向剂量方面的影响,并确定潜在变异性的相关参数。选择了四种通常被粉碎的儿科药物:胺碘酮、华法林、氢化可的松和卡托普利。每个片剂均使用破碎机装置在一个袋子中粉碎。粉碎后,使用口服注射器加入预定体积的水,然后抽取必要的体积以获得目标药物量。对于每种药物,药剂师和护士操作人员调查了 2 个靶向剂量(高和低)。使用相应的经验证的 HPLC 程序对每种混悬液进行了 3 次测定。使用 GraphPad Prism®进行统计学分析,以评估操作人员、袋子中的抽吸水平和实际药物剂量的影响。为了研究制剂改变对注射器中药物含量的影响,选择了五种通用的胺碘酮药物。使用单因素方差分析比较了注射器的含量。注射器中的药物损失率为 8.1%至 54.1%。胺碘酮的药物损失率为 18.9%至 30.5%,卡托普利为 0.1%至 5.5%,华法林为 5.6%至 19.7%,氢化可的松为 5.0%至 30.7%。混悬液采样水平的比较在胺碘酮、氢化可的松和华法林中存在显著差异。操作人员的比较显示药剂师和护士之间存在显著差异(p=0.0251)。最后,对 5 种通用的胺碘酮药物进行比较,发现使用原始药物与使用仿制药相比,获得的注射器内容物存在一些统计学差异。每个药物物质的物理化学性质和药物产品的制剂都可能是需要考虑的因素。因此,将片剂粉碎后加水口服需要逐个进行评估。尽管缺乏适当的儿科制剂,但不建议将粉碎的材料混悬于给定体积的水中,因为这远非良好的实践。